FDA Approves New Drug to Treat Alzheimer's, Kisunla
Drugs.com
JULY 2, 2024
TUESDAY, July 2, 2024 -- A new drug to treat Alzheimer's disease was approved by the U.S. In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early. Food and Drug Administration on Tuesday.
Let's personalize your content